Drugs / Optive Lubricant Eye Drops
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03380624 | Mar 2017 → Jun 2018 | dry eye syndrome | Ohio State University | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01207752 Comparator | Sep 2010 → Jul 2011 | eye adnexa disorder | Southern California College of Optometry at Marshall B. Ketchum University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Optive Lubricant Eye Drops | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01207752 ↗ |
| Known as | Refresh Optive | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03380624 ↗ |
| Modality | Other / unclassified | “two US Monograph lubricant eyedrop formulations” NCT03380624 ↗ |
| Route | Topical | “Artificial tear eye drop” NCT01207752 ↗ |